Q2 2021 Iteos Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the iTeos Therapeutics second-quarter 2021 financial results conference call. My name is Emily, and I will be your moderator today. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Ryan Baker, Head of Investor Relations at iTeos. Please proceed.
Thank you for joining us today. Joining me from iTeos with prepared remarks are Michel Detheux, President and CEO; and Matthew Gall, Chief Financial Officer; Dr. Joanne Lager, Chief Medical Officer, will be available for Q&A.
Before we begin, I would like to remind you all that the team will be making forward-looking statements in the prepared remarks and during the Q&A session. Any statements made during this call that are not statements of historical or current facts are intended to be forward-looking statements pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
We want to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |